Preparing for the FDA Patient-Focused Drug Development Meeting on Alopecia Areata

preview_player
Показать описание
Be as prepared as possible so you can make the most impact! Hear from NAAF staff members, Dane Christiansen (Vice-President of the Health & Medicine Counsel of Washington) and Teresa Barnes (a patient advocate who has participated in a previous FDA meeting) about the stated goals of the meeting, the exact questions which will be raised for discussion, and what to expect.
  1. National Alopecia Areata Foundation
Рекомендации по теме
Preparing for the 0:56:38

Preparing for the FDA Patient-Focused Drug Development Meeting on Alopecia Areata

Webinar: Preparing for 0:36:50

Webinar: Preparing for the Patient-Focused Drug Development Meeting on Sarcopenia

NPF Webinar: FDA 0:52:10

NPF Webinar: FDA Patient-focused drug development meeting prep

FDA Patient Focused 0:09:21

FDA Patient Focused Drug Development Meeting - Overview of FDA PFDD Initiative

Public Webinar: Patient-Focused 2:34:13

Public Webinar: Patient-Focused Drug Development Draft Guidance 3

Public Meeting: Using 1:57:53

Public Meeting: Using Methods from PFDD Guidance 1 and Guidance 2 Meeting #2

FDA Patient-Focused Drug 0:26:40

FDA Patient-Focused Drug Development Meeting - Topic 2: Current Approaches to Treatment

FDA Patient-Focused Drug 1:09:33

FDA Patient-Focused Drug Development Meeting - Large Group Discussion on Topic #2

FDA Patient Focused 0:03:10

FDA Patient Focused Drug Development Meeting - Opening Remarks

FDA Patient Focused 0:09:37

FDA Patient Focused Drug Development Meeting - Background on Vitiligo

Virtual Public Meeting 5:18:41

Virtual Public Meeting on Patient-Focused Drug Development for Long COVID

FDA Patient-Focused Drug 1:00:54

FDA Patient-Focused Drug Development Meeting - Large Group Discussion on Topic #1

Public Meeting on 1:48:56

Public Meeting on Patient Focused Drug Development for Non Tuberculous Mycobacterial Infections Pt 1

Nonprofit Forum 2013: 1:01:19

Nonprofit Forum 2013: FDA: Patient Focused Drug Program

Patient-reported outcomes and 0:59:51

Patient-reported outcomes and the FDA Patient-Focused Drug Development Guidance

Patient-Focused Drug Development: 1:11:16

Patient-Focused Drug Development: Methods to Identify What Is Important to Patients

Public Meeting on 2:34:48

Public Meeting on Patient Focused Drug Development for Alpha 1 Antitrypsin Part 1

Public Meeting: Patient-Focused 3:58:26

Public Meeting: Patient-Focused Drug Development for Systemic Sclerosis

Public Meeting: Patient-Focused 2:30:29

Public Meeting: Patient-Focused Drug Development for Hereditary Angioedema (Part 1 of 2)

Public Meeting on 1:55:15

Public Meeting on Patient Focused Drug Development for People Who Received an Organ Transplant Pt. 1

Public Meeting: Patient-Focused 3:57:57

Public Meeting: Patient-Focused Drug Development for Vitiligo

2022 Externally-Led Patient-Focused 1:02:02

2022 Externally-Led Patient-Focused Drug Development - Informational Meeting

Public Meeting: Patient-Focused 1:58:05

Public Meeting: Patient-Focused Drug Development for Fibromyalgia (Part 1 of 2)

The Voices of 0:55:45

The Voices of the Ataxia Community - An Introduction to Patient Focused Drug Development